4 CCR 749-1.8 - Definitions

The purpose of this Rule is to define terms used in these Rules and the Naturopathic Doctor Act.

A. "ACIP" means the Advisory Committee on Immunization Practices to the Centers for Disease Control and Prevention in the federal Department of Health and Human Services or its successor entity.

B. "Administer" shall have the same meaning as the definition set forth in section 12-250-103(2), C.R.S., and means the direct application of a drug to the body of a patient by injection, inhalation, ingestion, or any other method.

C. "Collaborative Agreement" means a written agreement executed between a naturopathic doctor and a Colorado licensed physician who is a pediatrician or a family physician. The agreement shall include the duties and responsibilities of each party as part of the collaborative agreement according to each party's standard of care and practice act. The agreement shall include a process for consulting with and referring to a licensed physician to facilitate the effective treatment of children under the age of two years.

D. "Collaborative Relationship" means a cooperative relationship among a patient's health care providers; to share information and consult with one another as appropriate to achieve the best health care outcomes for the patient.

E. "Dispense" shall have the same meaning as the definition set forth in section 12-250-103(7), C.R.S., and means the preparation, in a suitable container appropriately labeled for subsequent administration to or use by a patient, of a medicine that a naturopathic doctor is authorized to obtain.

F. "Licensed Pediatric Health Care Provider" means a licensed physician, an advanced practice nurse, or a certified midwife who treats children.

G. "Naturopathic Formulary" means the medications and devices listed in Rule 1.7 (Sections 12-250-103(12) and 12-250-106(1)(c), C.R.S.)

Notes

4 CCR 749-1.8

37 CR 15, August 10, 2014, effective 8/30/2014 38 CR 11, June 10, 2015, effective 7/1/2015 39 CR 11, June 10, 2016, effective 6/30/2016 43 CR 03, February 10, 2020, effective 1/1/2020 43 CR 07, April 10, 2020, effective 4/30/2020 43 CR 22, November 25, 2020, effective 12/15/2020 44 CR 09, May 10, 2021, effective 5/30/2021 45 CR 17, September 10, 2022, effective 8/15/2022 45 CR 16, August 25, 2022, effective 9/14/2022 45 CR 21, November 10, 2022, effective 11/30/2022 46 CR 17, September 10, 2023, effective 8/22/2023, exp. 12/20/2023 (Emergency) 46 CR 18, September 25, 2023, effective 10/15/2023